Pages that link to "Q38778988"
Jump to navigation
Jump to search
The following pages link to Pursuit of a perfect insulin. (Q38778988):
Displaying 43 items.
- Insulin analogues in type 1 diabetes mellitus: getting better all the time (Q38692387) (← links)
- Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation. (Q38989309) (← links)
- Development of glucose-responsive 'smart' insulin systems (Q39309814) (← links)
- Oral Insulin Delivery in a Physiologic Context: Review (Q39400642) (← links)
- Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides (Q41077825) (← links)
- Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs (Q41139895) (← links)
- Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation (Q42655468) (← links)
- Glucose-responsive insulin by molecular and physical design (Q44875590) (← links)
- Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis (Q45068915) (← links)
- Synthetic "smart gel" provides glucose-responsive insulin delivery in diabetic mice. (Q47121485) (← links)
- 'Borono-lectin' based engineering as a versatile platform for biomedical applications (Q47131624) (← links)
- An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein (Q47371507) (← links)
- Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding (Q47371515) (← links)
- 4S-Hydroxylation of Insulin at ProB28 Accelerates Hexamer Dissociation and Delays Fibrillation. (Q47574222) (← links)
- Chemically Precise Glycoengineering Improves Human Insulin. (Q47579138) (← links)
- Small Scaffolds, Big Potential: Developing Miniature Proteins as Therapeutic Agents (Q47965403) (← links)
- Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii (Q48287561) (← links)
- Selective lysine modification of native peptides via aza-Michael addition (Q48677748) (← links)
- Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction (Q49391770) (← links)
- A glucose-responsive insulin therapy protects animals against hypoglycemia (Q50101787) (← links)
- Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study (Q51057720) (← links)
- β-cell-mimetic designer cells provide closed-loop glycemic control (Q51082067) (← links)
- Ascorbate as a pro-oxidant: mild N-terminal modification with vinylboronic acids (Q51187158) (← links)
- Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians. (Q51744512) (← links)
- The European Medicines Agency's approval of new medicines for type 2 diabetes (Q57163307) (← links)
- Leveraging Physiology for Precision Drug Delivery (Q57428850) (← links)
- Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target (Q59138094) (← links)
- Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug (Q61796165) (← links)
- From venom peptides to a potential diabetes treatment (Q61796590) (← links)
- O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo Activity (Q68687096) (← links)
- Trans-toxin ion-sensitivity of charybdotoxin-blocked potassium-channels reveals unbinding transitional states (Q83230881) (← links)
- Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts (Q88058879) (← links)
- Amino acid-based compound activates atypical PKC and leptin receptor pathways to improve glycemia and anxiety like behavior in diabetic mice (Q89744665) (← links)
- Novel four-disulfide insulin analog with high aggregation stability and potency (Q89941132) (← links)
- Structure-guided engineering of TGF-βs for the development of novel inhibitors and probing mechanism (Q90347478) (← links)
- Advances in transdermal insulin delivery (Q90354103) (← links)
- Display of Single-Chain Insulin-like Peptides on a Yeast Surface (Q90691986) (← links)
- Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties (Q91039528) (← links)
- A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making (Q92336679) (← links)
- Profiling Insulin Oligomeric States by 1H NMR Spectroscopy for Formulation Development of Ultra-Rapid-Acting Insulin (Q92869660) (← links)
- Multifunctional Nanocarriers for Lung Drug Delivery (Q92881451) (← links)
- In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules (Q97887227) (← links)
- Molecular engineering of safe and efficacious oral basal insulin (Q97904802) (← links)